Mihaela Aldea
机构：Institut Gustave Roussy, Dana-Farber Cancer Institute · ORCID：0000-0001-7685-051X
发表论文 360 篇 · 总被引 2768 次 · h-index 26
代表论文
- ESMO basic requirements for AI-based biomarkers in oncology (EBAI) (2025 · Annals of Oncology · 被引 32)
- Next-generation multicenter studies: using artificial intelligence to automatically process unstructured health records of patients with lung cancer across multiple institutions (2025 · Annals of Oncology · 被引 4)
- Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50% (2025 · ESMO Open · 被引 4)
- Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patients (2025 · npj Precision Oncology · 被引 2)
- Presenting Features and Outcomes to Standard Systemic Therapies in Patients with MTAP -Deleted Advanced Non–Small Cell Lung Cancer (2026 · Clinical Cancer Research)
- Supplementary Data1 from Retreatment with First-Generation Selective RET Inhibitors in <i>RET</i>-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry (2026)